Schrodinger Inc (NASDAQ: SDGR) stock fell -0.06% on Friday to $30.86 against a previous-day closing price of $30.88. With 0.96 million shares changed hands, the volume of the stock remained heavier than its average volume of 0.79 million shares. During the session, the Health Information Services company that operates in wider Healthcare sector, reached to the highest price of $31.45 whereas the lowest price it dropped to was $30.39. The 52-week range on SDGR shows that it touched its highest point at $59.24 and its lowest point at $15.85 during that stretch. It currently has a 1-year price target of $48.22. Beta for the stock currently stands at 1.56.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of SDGR was up-trending over the past week, with a rise of 12.92%, but this was up by 36.85% over a month. Three-month performance dropped to -15.91% while six-month performance fell -6.80%. The stock gained 46.60% in the past year, while it has gained 65.12% so far this year. A look at the trailing 12-month EPS for SDGR yields 0.56 with Next year EPS estimates of -1.83. For the next quarter, that number is -0.40. This implies an EPS growth rate of 129.23% for this year and -397.76% for next year. EPS is expected to decline by -4.30% annually over the next five years; however, over the past five years, the company experienced an annual growth rate of -50.12%.
Float and Shares Shorts:
At present, 62.16 million SDGR shares are outstanding with a float of 61.33 million shares on hand for trading. On Oct 30, 2023, short shares totaled 6.94 million, which was 9.64% higher than short shares on Sep 28, 2023. In addition to Dr. Ramy Farid Ph.D. as the firm’s CEO, President & Director, Dr. Richard A. Friesner Ph.D. serves as its Co-Founder, Scientific Advisory Chairman and Director.
Through their ownership of 83.96% of SDGR’s outstanding shares, institutional investors have majority control over the company.
Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for SDGR since 0 analysts follow the stock currently. In the same way, a target price assigned to a stock can also reveal much about its potential. With SDGR analysts setting a high price target of $80.00 and a low target of $29.00, the average target price over the next 12 months is $48.22. Based on these targets, SDGR could surge 159.24% to reach the target high and fall by -6.03% to reach the target low. Reaching the average price target will result in a growth of 56.25% from current levels.
Summary of Insider Activity:
Insiders traded SDGR stock several times over the past three months with 1 Buys and 0 Sells. In these transactions, 4,545 shares were bought while 0 shares were sold. The number of buy transactions has increased to 22 while that of sell transactions has risen to 8 over the past year. The total number of shares bought during that period was 245,586 while 161,736 shares were sold.